欢迎来到天天文库
浏览记录
ID:32843047
大小:1.33 MB
页数:33页
时间:2019-02-16
《参芪复脉汤对阵发性房颤患者p波离散度影响的临床观察》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、陕西中医学院硕士学位论文参芪复脉汤对阵发性房颤患者P波离散度影响的临床观察姓名:郭红伟申请学位级别:硕士专业:中西医结合临床指导教师:郝伟201204中文摘要目的:观察参芪复脉汤联合胺碘酮对阵发性房颤患者临床疗效及对心电图P波离散度的影响,探讨其作用机制,促进其临床应用。方法:将60例阵发性房颤患者随机分为对照组(n=30)和试验组(n=30)。对照组给予胺碘酮口服,试验组给予胺碘酮及参芪复脉汤口服,疗程四周。观察两组治疗前和治疗后临床疗效、心电图、P波离散度(Pd)、P波最大时限(Pmax)的变化情况及安全性。结果:1.治疗后两组临床疗效比较:
2、试验组总有效率为93.33%,对照组为73.33%,两组比较有显著性差异(PO.05)。3.治疗后两组Pd、Pmax的比较:试验组的Pd、Pmax水平较对照组显著下降,有显著性差异(P3、汤具有抗心律失常的作用,是治疗阵发性房颤的安全有效方剂。关键词:阵发性房颤;参芪复脉汤;胺碘酮;P波离散度;P波最大时限TheCIinicaIObservationofEffectofShenqifumaiDecoctionP1『IfaVeDispersioninPatientsWithParoxysmaIAtriaIFibriIIationAbstractObjective:Toobserveclinicaltherapeuticeffectofshenqifumaidecoctioncombinedwithamiodaroneonparoxy4、smalatrialfibrillationinpatientsandimpactonp-wavedispersioninelectrocardiogram,andtoexploreitsmechanism,topromotetheirclinicalapplication.Method:60casesofparoxysmalatrialfibrillationpatientswererandomlydividedintocontrolgroup(n=30)andtestgroup(n=30).Thecontrolgroupweregivenor5、alamiodarone,whilethetestgroupweregivenoralamiodaroneandshenqifumaidecoction.Thetreatmentlasted4weeks.Theclinicaleffectandsecurityoftwogroupswereobservedbeforetreatmentandaftertreatment.changesofECG,p-wavedispersion(Pd),p-wavemaximumtime(Pmax)werealsoobservedsynchronically.Re6、suIts:1.Thecomparisonofclinicalefficacy:Thetotaleffectiveratewas93.33%intestgroupand73.33%incontrolgroup.Therewassignificantdifferencebetweentwogroups(P7、differencebetweentwogroups(P>O.05).3.ThecomparisonofPd,Pmaxlevel:TherewasmarkedreductionofPd,Pmaxlevelsintestgroupthanthecontrolgroup.Therewassignificantdifferencebetweentwogroups(P8、.67%incontrolgroup.Theresignificantdifferencebetweentwogroups(P
3、汤具有抗心律失常的作用,是治疗阵发性房颤的安全有效方剂。关键词:阵发性房颤;参芪复脉汤;胺碘酮;P波离散度;P波最大时限TheCIinicaIObservationofEffectofShenqifumaiDecoctionP1『IfaVeDispersioninPatientsWithParoxysmaIAtriaIFibriIIationAbstractObjective:Toobserveclinicaltherapeuticeffectofshenqifumaidecoctioncombinedwithamiodaroneonparoxy
4、smalatrialfibrillationinpatientsandimpactonp-wavedispersioninelectrocardiogram,andtoexploreitsmechanism,topromotetheirclinicalapplication.Method:60casesofparoxysmalatrialfibrillationpatientswererandomlydividedintocontrolgroup(n=30)andtestgroup(n=30).Thecontrolgroupweregivenor
5、alamiodarone,whilethetestgroupweregivenoralamiodaroneandshenqifumaidecoction.Thetreatmentlasted4weeks.Theclinicaleffectandsecurityoftwogroupswereobservedbeforetreatmentandaftertreatment.changesofECG,p-wavedispersion(Pd),p-wavemaximumtime(Pmax)werealsoobservedsynchronically.Re
6、suIts:1.Thecomparisonofclinicalefficacy:Thetotaleffectiveratewas93.33%intestgroupand73.33%incontrolgroup.Therewassignificantdifferencebetweentwogroups(P7、differencebetweentwogroups(P>O.05).3.ThecomparisonofPd,Pmaxlevel:TherewasmarkedreductionofPd,Pmaxlevelsintestgroupthanthecontrolgroup.Therewassignificantdifferencebetweentwogroups(P8、.67%incontrolgroup.Theresignificantdifferencebetweentwogroups(P
7、differencebetweentwogroups(P>O.05).3.ThecomparisonofPd,Pmaxlevel:TherewasmarkedreductionofPd,Pmaxlevelsintestgroupthanthecontrolgroup.Therewassignificantdifferencebetweentwogroups(P8、.67%incontrolgroup.Theresignificantdifferencebetweentwogroups(P
8、.67%incontrolgroup.Theresignificantdifferencebetweentwogroups(P
此文档下载收益归作者所有